- Home
- ADAG vs OVID Comparison
ADAG vs OVID Comparison
Compare ADAG & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- OVID
- Stock Information
- Founded
- ADAG 2011
- OVID 2014
- Country
- ADAG China
- OVID United States
- Employees
- ADAG N/A
- OVID N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- ADAG Health Care
- OVID Health Care
- Exchange
- ADAG Nasdaq
- OVID Nasdaq
- Market Cap
- ADAG 110.8M
- OVID 117.3M
- IPO Year
- ADAG 2021
- OVID 2017
- Fundamental
- Price
- ADAG $1.79
- OVID $1.63
- Analyst Decision
- ADAG Strong Buy
- OVID Strong Buy
- Analyst Count
- ADAG 3
- OVID 4
- Target Price
- ADAG $7.67
- OVID $3.13
- AVG Volume (30 Days)
- ADAG 78.0K
- OVID 5.3M
- Earning Date
- ADAG 08-12-2025
- OVID 11-11-2025
- Dividend Yield
- ADAG N/A
- OVID N/A
- EPS Growth
- ADAG N/A
- OVID N/A
- EPS
- ADAG N/A
- OVID N/A
- Revenue
- ADAG $103,204.00
- OVID $6,651,000.00
- Revenue This Year
- ADAG $7,411.34
- OVID $1,086.57
- Revenue Next Year
- ADAG $28.29
- OVID N/A
- P/E Ratio
- ADAG N/A
- OVID N/A
- Revenue Growth
- ADAG N/A
- OVID 1070.95
- 52 Week Low
- ADAG $1.33
- OVID $0.24
- 52 Week High
- ADAG $3.16
- OVID $2.01
- Technical
- Relative Strength Index (RSI)
- ADAG 41.71
- OVID 54.09
- Support Level
- ADAG $1.75
- OVID $1.50
- Resistance Level
- ADAG $1.95
- OVID $1.68
- Average True Range (ATR)
- ADAG 0.12
- OVID 0.14
- MACD
- ADAG -0.01
- OVID -0.03
- Stochastic Oscillator
- ADAG 20.32
- OVID 38.60
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.